HK Stock Market Move | HAIZHI TECH GP (02706) surges over 9%; the company is expected to be included in the Hang Seng TECH Index; Atlas agent revenue drives a surge in core revenue.

HAIZHI TECH GP (02706) surged over 9%, up 9.47% as of press time, at HK$31.08, with a turnover of HK$45.0525 million. On the news front, HAIZHI TECH GP announced that the company recently entered into a strategic cooperation framework agreement with Jointown Pharmaceutical Group. Pursuant to the strategic cooperation framework agreement, the company and Jointown Pharmaceutical Group will carry out strategic cooperation around the digital and intelligent transformation of the pharmaceutical distribution industry, including but not limited to using Atlas graph solutions and Atlas agents as carriers. The strategic cooperation contemplated under the strategic cooperation framework agreement will achieve resource complementarity and synergistic development, facilitating the digital and intelligent transformation (i.e., AI upgrade) of the pharmaceutical distribution industry. It is also worth noting that Huatai recently updated its Hang Seng TECH Index inclusion forecast, and HAIZHI TECH GP remains on the predicted inclusion list. The company, driven by its Atlas agent revenue, saw core revenue surge, laying a foundation for long-term development and is expected to be one of the candidates for index reshuffling in this round of adjustment. According to HAIZHI TECH GP's interim results report, the company's core growth engine, the Atlas agent business, recorded revenue of RMB 115 million, a sharp year-on-year increase of 135.6%, forming a "dual-wheel drive" development pattern with the traditional Atlas graph business. This validates the long-term prosperity of the "graph + controllable AI" industry route and provides a development foundation within the growth group.